Whole Blood vs Serum-Derived Exosomes for Host and Pathogen-Specific Tuberculosis Biomarker Identification: RNA-Seq-Based Machine-Learning Approach
- PMID: 39715973
- DOI: 10.1007/s10528-024-11002-1
Whole Blood vs Serum-Derived Exosomes for Host and Pathogen-Specific Tuberculosis Biomarker Identification: RNA-Seq-Based Machine-Learning Approach
Abstract
Mycobacterium tuberculosis (Mtb) remains a leading infectious disease responsible for millions of deaths. RNA sequencing is a rapidly growing technique and a powerful approach to understanding host and pathogen cross-talks via transcriptional responses. However, its application is limited due to the high costs involved.This study is a preliminary attempt to understand host-pathogen cross-talk during TB infection in different TB clinical cohorts using two biological fluids: Whole blood and serum exosomes (EXO). We conducted an RNA-sequencing machine-learning approach using 20 active TB (ATB), 11 latent TB (LTB), three healthy control (HC) whole blood datasets, and two ATB, LTB, and HC serum EXO datasets. During the study, host-derived differentially expressed genes (DEGs) were identified in both whole blood and EXOs, while EXOs were successful in identifying pathogen-derived DEGs only in LTB. The majority of the DEGs in whole blood were up-regulated between ATB and HC, and ATB and LTB, while down-regulated between LTB and HC, which was vice versa for the EXOs, indicating different mechanisms in response to different states of TB infection across the two different biological samples. The pathway analysis revealed that whole blood gene signatures were mainly involved in host immune responses, whereas exosomal gene signatures were involved in manipulating the host's cellular responses and supporting Mtb survival. Overall, identifying both host and pathogen-derived gene signatures in different biological samples for intracellular pathogens like Mtb is vital to decipher the complex interplay between the host and the pathogen, ultimately leading to more successful future interventions.
Keywords: Biomarkers; Exosomes; Machine learning; RNA sequencing; Tuberculosis; Whole blood.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflicts of interest: The authors declare no competing interests.
Similar articles
-
RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Active and Latent Mycobacterium tuberculosis Infection.Front Microbiol. 2017 Jun 12;8:1051. doi: 10.3389/fmicb.2017.01051. eCollection 2017. Front Microbiol. 2017. PMID: 28659881 Free PMC article.
-
Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq.J Infect. 2022 Nov;85(5):534-544. doi: 10.1016/j.jinf.2022.08.017. Epub 2022 Aug 22. J Infect. 2022. PMID: 36007657
-
New genetic biomarkers from transcriptome RNA-sequencing for Mycobacterium tuberculosis complex and Mycobacterium avium complex infections by bioinformatics analysis.Sci Rep. 2024 Jul 29;14(1):17385. doi: 10.1038/s41598-024-68242-9. Sci Rep. 2024. PMID: 39075154 Free PMC article.
-
Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures.PLoS Med. 2019 Apr 23;16(4):e1002786. doi: 10.1371/journal.pmed.1002786. eCollection 2019 Apr. PLoS Med. 2019. PMID: 31013272 Free PMC article.
-
The role of Mycobacterium tuberculosis exosomal miRNAs in host pathogen cross-talk as diagnostic and therapeutic biomarkers.Front Microbiol. 2024 Aug 8;15:1441781. doi: 10.3389/fmicb.2024.1441781. eCollection 2024. Front Microbiol. 2024. PMID: 39176271 Free PMC article. Review.
References
-
- Alipoor SD, Tabarsi P, Varahram M et al (2019) Serum exosomal miRNAs are associated with active pulmonary tuberculosis. Dis Markers. https://doi.org/10.1155/2019/1907426 - DOI - PubMed - PMC
-
- Banada PP, Koshy R, Alland D (2013) Detection of Mycobacterium tuberculosis in blood by use of the Xpert MTB/RIF assay. J Clin Microbiol 51:2317–2322. https://doi.org/10.1128/JCM.00332-13 - DOI - PubMed - PMC
-
- Barker E, Moss J, Holmes H et al (2023) A cost-effectiveness evaluation of latent tuberculosis infection screening of a migrant population in Malaysia. Sci Rep 13:1–11. https://doi.org/10.1038/s41598-023-29648-z - DOI
-
- Bo H, Moure UAE, Yang Y et al (2023) Mycobacterium tuberculosis-macrophage interaction: molecular updates. Front Cell Infect Microbiol 13:1–14. https://doi.org/10.3389/fcimb.2023.1062963 - DOI
-
- Burel JG, Singhania A, Dubelko P et al (2021) Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease. Tuberculosis 131:102127. https://doi.org/10.1016/j.tube.2021.102127 - DOI - PubMed
LinkOut - more resources
Full Text Sources